Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Current Challenges and Personalized Treatment in Cardiovascular Disease"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 10 November 2023 | Viewed by 5427
Special Issue Editor
Interests: evidence based medicine; cardiac surgery; thoracic aorta diseases; heart valve diseases; minimal invasive cardiac surgery; congenital heart disease; outcomes; cardiovascular disease pathologies; cardiovascular disease treatments, biomarkers in cardiovascular disease; pediatric cardiac surgery; pediatric cardiac surgery intensive care; critical care patients
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Cardiovascular disease is the most common cause of death in developing and developed countries. Advanced coronary artery disease, heart valve disease, thoracic aorta disease, congenital heart disease and progressive heart failure negatively affect quality of life and reduce the survival rate of patients.
Acute aortic syndrome, including acute type A dissection, remains a life-threatening disease, even if it is treated surgically. Increasing age and the severe comorbidities of patients who are referred to hospital for the management of cardiovascular disease add additional risk factors for morbidity and mortality. On the other hand, congenital heart diseases constitute the minority of overall heart diseases, but the management of these patients is a challenge for modern cardiology and cardiac surgery. New minimally invasive cardiac surgery techniques contribute to minimizing the surgical stress of patients who undergo cardiac surgery. Newest transcatheter heart valve intervention techniques in patients with high or prohibitive risk for surgery offer an alternative therapeutic choice for these patients. Mechanical circulatory support increases survival expectancy in patients with end-stage heart failure. In addition, novel cardiovascular biomarkers offer the opportunity to predict and monitor cardiovascular disease. The personalized and targeted management of patients based on the current guidelines, innovation techniques and decisions of the heart team could offer the best results for patients with advanced cardiovascular disease.
The purpose of this Special Issue is to present the outcomes of current management and intervention techniques for patients with advanced cardiovascular diseases.
The cutting-edge researches of cardiovascular disease are minimally invasive cardiac surgery; transcatheter heart valve interventions; mechanical circulatory support; ECMO; biomarkers.
We welcome you to submit your research articles, in the form of original research articles and reviews.
Dr. Georgios Samanidis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- evidence-based medicine
- thoracic aorta diseases
- minimally invasive cardiac surgery
- transcatheter heart valve interventions
- heart failure
- cardiac tumors
- critical cardiac surgery patients
- congenital heart disease
- biomarkers and cardiovascular disease